Simulations Plus, Inc.

Healthcare · Health Information Services · United States

Last price 18.5 USD (At close: Oct 5, 2026) · Market cap 374.16M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym...